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Case ReportsDISCUSSION
Aspergillus is a rare cause of endocarditis.1-3 The prognosis
for AE is poor, with only a third of reported patients surviving
the acute episode, in part because of immunocompromise,
delay in diagnosis, systemic dissemination, and multiple
embolic episodes.1 Only 5 cases of infective endocarditis
caused by the species A terreus have been reported.1 To the
best of our knowledge, this is the first reported case of pros-
thetic valve endocarditis caused by A terreus.
Early and accurate diagnosis is the most critical step in
the treatment of AE and requires a high index of suspicion.
The occurrence of peripheral emboli is the most common
presenting feature and in a culture-negative infective endo-
carditis setting should raise the suspicion of AE.1,3,4
Echocardiography reveals large vegetations on the
valve(s), but blood cultures are almost always negative.1-3
Ultimately, the diagnosis of Aspergillus requires histology
and tissue culture confirmation from vegetations or
emboli. Determining species is critical, because A terreus
species is almost always resistant to amphotericin B, and
voriconazole is the antifungal drug of choice, often in
combination with an echinocandin.1
Mortality is extremely high among those who receive
antifungal therapy alone.1-3 Successful treatment of AE
requires combination of appropriate antifungal therapy and
radical surgical debridement. Despite adequate combined
antifungal and radical surgical treatment, recurrence after
AE as high as 40% has been reported, adding to the dismal
prognosis.1-3 As a consequence, we now recommend
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The Journal of Thoracic and CarOur patient was not immunosuppressed. El-Hamamsy
and colleagues reported a cluster of 3 immunocompetent
cases of AE after aortic valve replacement in which the
source could not be identified.5 They suggested seeding
by airborne spores as probable cause, emphasizing impor-
tance of operating room sterility and use of high-
efficiency particulate air filters.
In conclusion, AE is a rare, often fatal infection requiring
a high index of suspicion, multidisciplinary team approach
for expeditious and accurate diagnosis, and appropriate anti-
fungal and surgical treatment. Diagnosis requires histology
and culture. Species diagnosis of AE is critical, because
A terreus is resistant to amphotericin B. Immediate surgical
intervention with radical debridement and lifelong
antifungal therapy remains the best hope of improved
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ventricular septal defect associated with an MYH7 mutation
Keiichi Hirono,MD,a Yukiko Hata, PhD,b Keijirou Ibuki, MD,a and Naoki Yoshimura,MD,c Toyama, JapanLeft ventricular noncompaction (LVNC) is a rare cardiomy-
opathy characterized by prominent trabeculations with deep
intertrabecular recesses.1 Ebstein’s anomaly is a
rare congenital heart defect, and familial cases areuncommon.2,3 These genetic causes have not been fully
elucidated.
We describe clinical and molecular investigations of a rare
case of familial Ebstein’s anomaly, LVNC, and ventricular
septal defect (VSD) in association with a likely pathogenic
novel mutation of the MYH7 (c.1085T>G, p.Met362Arg)
gene. The sister and brother have been diagnosed with Eb-
stein’s anomaly, LVNC, and VSD, and novel mutation was
identified in the sister, brother, and father.
CLINICAL SUMMARY
Case 1 (the Proband)
The patient was a full-term infant with a birth weight
of 3.42 kg and Apgar scores of 9 and 10 at 1 and 5diovascular Surgery c Volume 148, Number 5 e223
FIGURE 1. Echocardiographic images of case 1 (A and B) and case 2 (C and D). In case 1, apical 4-chamber view shows the characteristic left ventricular
myocardium without (A) and with (B) color flow visible in intertrabecular recesses on color Doppler images. In case 2, apical 4-chamber view shows the
characteristic left ventricular myocardium without (C) and with (D) color flow visible in intertrabecular recesses on color Doppler images. LA, Left atrium;
LV, left ventricle; RA, right atrium; RV, right ventricle.
Case Reportsminutes, respectively. At 4 days of age, a precordial sys-
tolic murmur was audible, and the baby was referred to
the Graduate School of Medicine. Echocardiography re-
vealed mild apical displacement of the tricuspid valve,
indicating mild Ebstein’s anomaly with moderate
tricuspid valve insufficiency and right heart enlargement,
atrial septal defect, membranous VSD, and LVNC
(Figure 1). Criteria used for the echocardiographic diag-
nosis of LVNC were the presence of prominent or
numerous left ventricular trabeculations over the 1-wall
segment of the left ventricle, 2-layered appearance of
the myocardium with an increased noncompacted to
compacted ratio (suggested as>2.0), and multiple deep
intertrabecular recesses communicating with the ventric-
ular cavity, as demonstrated by color Doppler imag-
ing.1,4 At 11 days of age, the baby was symptomatic,
feeding poorly, pale, and poorly perfused, with
tachypnea and tachycardia. She underwent repair of the
atrial septal defect and VSD at the age of 16 days.
However, her heart failure symptoms did not improve.
Coarctation of the aorta was identified by differences
in blood pressures between the upper limb and thee224 The Journal of Thoracic and Cardiovascular Surlower limb, and arch repair was performed at the age
of 1 month.
At 3 years of follow-up, the patient is doing well, with
normal growth and development, but she continues to
have echocardiographic features of LVNC with abnormal
myocardial relaxation (Figure 1).
Case 2 (Her Brother)
Fetal echocardiography at 26weeks revealed that the fetus
also had mild Ebstein’s anomaly and VSD. The patient was
born as a full-term male infant with a birth weight of 3.42 kg
and Apgar scores of 8 and 8 at 1 and 5 minutes, respectively.
At 5 days of age, the baby became gradually symptomatic
with tachypnea and tachycardia and was admitted to our hos-
pital. Echocardiography revealed mild Ebstein’s anomaly,
VSD, and LVNC as identified in his sister (Figure 1). He un-
derwent VSD repair at the age of 1 month.
He is now aged 1 year and in good health. His cardiac
function has steadily improved to reach a left ventricular
ejection fraction of approximately 60%, but he continues
to have echocardiographic features of LVNCwith abnormal
myocardial relaxation (Figure 1).gery c November 2014
FIGURE 2. The pedigree of the family with Ebstein’s anomaly and LVNC (A) and genetic analysis (B). A, The proband is indicated by the arrow. Solid
symbols indicate individuals with Ebstein’s anomaly and LVNC; half solid symbols indicate individuals with LVNC; open symbols indicate unaffected
individuals. B, Sequence analysis of MYH7 reveals a change of methionine to arginine at position 362 in the proband, his sister, and his father. The
variant was considered likely pathogenic because of the following criteria: (1) presence in all affected members of the family; (2) absence from 400
unrelated chromosomes of the control subjects; (3) absence in the public databases, dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP/)
and National Heart, Lung, and Blood Institute GO Exome Sequencing Project (http://evs.gs.washington.edu/EVS/); (4) affecting evolutionary conserved
residues (nucleotide and amino acid); and (5) predicted deleterious/pathogenic by multiple in silico algorithms (Polyphen2, PANTHER, Align GVGD,
SHIFT, and Mutation Taster). No mutations were identified in the TAZ, LMNA/C, MYBPC3, TNNT2, TNNI3, ACTC, and TPM1 genes. LVNC, Left ven-
tricular noncompaction.
Case ReportsAt this time, we were able to obtain some additional
history from the parents. They have no limited exercise
tolerance and do not have dyspnea on exertion. The echo-
cardiogram revealed the father also has LVNC.MOLECULAR STUDIES
A novel MYH7 heterozygous missense variant
(NM_000257.2; c.1085T>G, p.Met362Arg) was identified
in the proband and his sister, and was inherited from their
father (Figure 2).DISCUSSION
Most cases of Ebstein’s anomaly are sporadic and famil-
ial cases are rare, but various associated cardiovascular ab-
normalities have been reported, including LVNC or
hypertrabeculation of the left ventricle and VSD.2,3
The MYH7 gene, localized on chromosome 14p12, is
composed of 41 exons and encodes the b-myosin heavy
chain, expressed in cardiac muscle. Mutations in MYH7
have been reported in individuals with Ebstein’s anom-
aly,5 especially those who also had LVNC. The
Met362Arg amino acid change in MYH7 is located in
the head region that contains all the necessary elements
to generate movement of actin relative to the myosinThe Journal of Thoracic and Carduring adenosine triphosphate hydrolysis, suggesting
that the MYH7 mutation is likely to diminish the force
generation of cardiac myocytes. The Met362Arg variant
has not been reported in cases of familial Ebstein’s anom-
aly. The family described supports autosomal dominant
inheritance of Ebstein’s anomaly, as suggested by previ-
ous reports.2,3CONCLUSIONS
This is the first report of familial Ebstein’s anomaly asso-
ciated with theMet362Argmutation of theMYH7 gene. Our
cases indicate that the evaluation of cardiac function, the
presence of additional congenital malformations and family
history, and the identification of the molecular defect within
the family are likely to be important before and after cardiac
surgery.References
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Genet. 2011;4:43-50.Right ventricular failure from severe pulmonary hypertension after
surgery for shone complex: Back to fetal physiology with reducting,
atrioseptectomy, and bilateral pulmonary arterial bandingHeiner Latus, MD, Can Yerebakan, MD, Dietmar Schranz, MD, and Hakan Akintuerk, MD, Giessen,
GermanyDeciding whether to create a univentricular or biventricular
circulation in patients with borderline left ventricular (LV)
structures in the neonatal period is challenging.We describe
a case in which we used a unique approach intended to
imitate cardiac physiology in a ‘‘fetal parallel circulation.’’
We call this procedure in neonates with borderline LV the
‘‘Giessen hybrid approach.’’1CLINICAL SUMMARY
A 15-month-old male patient was referred to our center
for evaluation of a potential cardiac transplant. Initial
diagnostic evaluation and subsequent surgical treatment
with neonatal repair of a coarctation of the aorta had
been performed in another center for Shone complex,
including mitral valve stenosis, LV outflow tract obstruc-
tion, stenotic bicuspid aortic valve, and a hypoplastic
aortic arch with severe aortic coarctation. Because of mul-
tiple life-threatening pulmonary hypertensive crises with
right heart failure, the patient underwent reoperation at
the age of 9 months. Reoperation included reconstruction
of the stenotic aortic valve and relief of the LV outflow
tract obstruction, followed by extracorporeal membrane
oxygenation treatment and early reoperation for severe
mitral regurgitation. Despite specific medical therapy
with sildenafil citrate (INN sildenafil), the patient was still
affected by PH with a severe precapillary component,resulting in suprasystemic pulmonary arterial pressure of
89/52/67 mm Hg and systemic arterial pressure of 69/
37/50 mm Hg (pulmonary capillary wedge pressure of
15 mm Hg) and leading to recurrent PH crises and epi-
sodes of cardiopulmonary resuscitation.
At the patient’s presentation in our center, echocardiogra-
phy showed a hypertrophied right ventricle (RV) and a sec-
ondary tricuspid regurgitation with a systolic gradient of
100 mm Hg (tricuspid valve annulus of 20 mm; z score of
0.7). The LV was small (LV internal dimension in diastole
of 22 mm; z score of 2), and the mean diastolic gradient
across the only minimal regurgitant mitral valve (annulus
of 10 mm; z score of 3) was 8 mm Hg (maximal value
of 16 mm Hg). The echogenic interventricular septum
deviated to the left, the LV outflow tract was narrowed to
5 mm, and the dysplastic and bicuspid aortic valve (annulus
of 6 mm; z score of 5) still had a maximal gradient of
60 mm Hg.
In light of the patient’s medical history with multiple life-
threatening events, the abnormalmorphology of the LVwith
endocardial fibroelastosis (Figure 1), and the large differ-
ence in the diameter of the pulmonary and aortic annulus
(12 mm vs 6 mm), we decided against a Ross-Konno opera-
tion and cardiac transplant and instead opted for a palliative
strategy. On the basis of our experience in neonates with a
borderline LV,1 an 8-mm polytetrafluoroethylene prosthesis
was positioned between the main pulmonary artery and the
distal aortic arch, thereby creating a ‘‘new arterial duct.’’
The operation was performed through a median sternotomy
with cardiopulmonary bypass at 30C. This strategy of a
‘‘reverse’’ aortopulmonary shunt was combined with atrial
septectomy and bilateral pulmonary arterial banding
(bPAB) with a 5-mm polytetrafluoroethylene graft. The pa-
tient could be discharged home on postoperative day 21 un-
der medical treatment with bosentan and sildenafil.
After an uneventful period of 4 months without any PH
crises, the patient was seen in improved clinical condition,gery c November 2014
